Rapt Therapeutics, Inc. (RAPT)

57.92 0.00 (0.00%) USD  |  NASDAQ  |  Feb 23, 13:59
More

Rapt Therapeutics Long Term Deferred Tax Liabilities (Quarterly)

Long Term Deferred Tax Liabilities (Quarterly) Chart

View Long Term Deferred Tax Liabilities (Quarterly) for RAPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Long Term Deferred Tax Liabilities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Long Term Deferred Tax Liabilities (Quarterly) Range, Past 5 Years

View Long Term Deferred Tax Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Long Term Deferred Tax Liabilities (Quarterly) Benchmarks

View Long Term Deferred Tax Liabilities (Quarterly) Benchmarks
Start Trial
Penumbra, Inc. --
Amicus Therapeutics, Inc. --
Johnson & Johnson Upgrade
Merck & Co., Inc. --
Pfizer Inc. --